Magazine Article | March 1, 2022

Shared Qualification Audits: A Win-Win-Win Approach

Source: Life Science Leader

By Enith Morillo

In November 2021, the FDA published an update to the Resiliency Roadmap for FDA Inspectional Oversight, sharing the agency’s success in grappling with the impact of COVID-19 on domestic and foreign inspections and its effective use of remote interactive evaluations to support surveillance activities.

Throughout the pandemic, the agency has demonstrated more than ever the value of using a risk-based approach to inspectional activities, which must be embraced and mirrored in industry when it comes to supplier and vendor audits, especially by early-stage pharmaceutical companies.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader